CSL Vifor has been a pioneer in the development of iron-based products and has established itself as a global leader in the treatment of iron deficiency.
Chronic kidney disease (CKD) is relatively common among adults, with prevalence of up to 13%1 and rising as the population ages. CSL Vifor strives to improve lives of people suffering from kidney diseases, through our broad, innovative nephrology portfolio and individualized solutions.
Popular search terms:
Americas
Asia Pacific
Middle East
Europe
